Stabilization of α‐chymotrypsin upon PEGylation correlates with reduced structural dynamics

Protein stability remains one of the main factors limiting the realization of the full potential of protein therapeutics. Poly(ethylene glycol) (PEG) conjugation to proteins has evolved into an important tool to overcome instability issues associated with proteins. The observed increase in thermodynamic stability of several proteins upon PEGylation has been hypothesized to arise from reduced protein structural dynamics, although experimental evidence for this hypothesis is currently missing. To test this hypothesis, the model protein α‐chymotrypsin (α‐CT) was covalently modified with PEGs with molecular weights (MW) of 700, 2,000 and 5,000 and the degree of modification was systematically varied. The procedure did not cause significant tertiary structure changes. Thermodynamic unfolding experiments revealed that PEGylation increased the thermal transition temperature (Tm) of α‐CT by up to 6°C and the free energy of unfolding [ΔGU (25°C)] by up to 5 kcal/mol. The increase in stability was found to be independent of the PEG MW and it leveled off after an average of four PEG molecules were bound to α‐CT. Fourier‐transformed infrared (FTIR) H/D exchange experiments were conducted to characterize the conformational dynamics of the PEG‐conjugates. It was found that the magnitude of thermodynamic stabilization correlates with a reduction in protein structural dynamics and was independent of the PEG MW. Thus, the initial hypothesis proved positive. Similar to the thermodynamic stabilization of proteins by covalent modification with glycans, PEG thermodynamically stabilizes α‐CT by reducing protein structural dynamics. These results provide guidance for the future development of stable protein formulations. Biotechnol. Bioeng. © 2008 Wiley Periodicals, Inc.

[1]  A. Hvidt,et al.  Hydrogen exchange in proteins. , 1966, Advances in protein chemistry.

[2]  A. Habeeb,et al.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. , 1966, Analytical biochemistry.

[3]  F. Davis,et al.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.

[4]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.

[5]  P. Privalov,et al.  Micro- and macro-stabilities of globular proteins , 1979, Nature.

[6]  Pace Cn,et al.  Measuring and increasing protein stability , 1990 .

[7]  E. Goormaghtigh,et al.  Tertiary stability of native and methionine-80 modified cytochrome c detected by proton-deuterium exchange using on-line Fourier transform infrared spectroscopy. , 1995, Biochemistry.

[8]  I. N. Topchieva,et al.  Synthesis and physicochemical properties of protein conjugates with water-soluble poly(alkylene oxides). , 1995, Bioconjugate chemistry.

[9]  Adenylate Kinase fromSulfolobus acidocaldarius:Expression inEscherichia coliand Characterization by Fourier Transform Infrared Spectroscopy , 1996 .

[10]  M. Domach,et al.  Polyethylene glycol-induced stabilization of subtilisin , 1996 .

[11]  Adenylate kinase from Sulfolobus acidocaldarius: expression in Escherichia coli and characterization by Fourier transform infrared spectroscopy. , 1996, Archives of biochemistry and biophysics.

[12]  G A Petsko,et al.  Adjustment of conformational flexibility is a key event in the thermal adaptation of proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Combes,et al.  Thermostability of modified enzymes : a detailed study , 1999 .

[14]  W Wang,et al.  Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.

[15]  W. Wang,et al.  Lyophilization and development of solid protein pharmaceuticals. , 2000, International journal of pharmaceutics.

[16]  J. Lee,et al.  Structure and dynamics of the modular halves of Escherichia coli cyclic AMP receptor protein. , 2002, Biochemistry.

[17]  B. Polakiewicz,et al.  Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli L-asparaginase. , 2002, International journal of pharmaceutics.

[18]  K. Griebenow,et al.  Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers , 2002, The Journal of pharmacy and pharmacology.

[19]  G. Saab-Rincón,et al.  High temperature biocatalysis by chemically modified cytochrome C. , 2002, Bioconjugate chemistry.

[20]  P. K. Smith,et al.  Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. , 2003, Bioconjugate chemistry.

[21]  G. Montich,et al.  Protein stability induced by ligand binding correlates with changes in protein flexibility , 2003, Protein science : a publication of the Protein Society.

[22]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[23]  A. D. Robertson,et al.  EX1 hydrogen exchange and protein folding. , 2004, Biochemistry.

[24]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[25]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[26]  Daniel E. Otzen,et al.  Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.

[27]  K. Griebenow,et al.  Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres. , 2005, Journal of pharmaceutical sciences.

[28]  R. J. Solá,et al.  Chemical glycosylation: New insights on the interrelation between protein structural mobility, thermodynamic stability, and catalysis , 2006, FEBS letters.

[29]  G. Viniegra-González,et al.  Thermostability of native and pegylated Myceliophthora thermophila laccase in aqueous and mixed solvents. , 2006, Bioconjugate chemistry.

[30]  R. J. Solá,et al.  Influence of modulated structural dynamics on the kinetics of alpha-chymotrypsin catalysis. Insights through chemical glycosylation, molecular dynamics and domain motion analysis. , 2006, The FEBS journal.

[31]  R. J. Solá,et al.  Engineering of protein thermodynamic, kinetic, and colloidal stability: Chemical Glycosylation with monofunctionally activated glycans , 2006, Biotechnology and bioengineering.

[32]  Yongjun Nie,et al.  Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin. , 2006, Bioconjugate chemistry.

[33]  K. Griebenow,et al.  On the relationship between the activity and structure of PEG‐α‐chymotrypsin conjugates in organic solvents , 2006, Biotechnology and bioengineering.

[34]  Hong Zhao,et al.  Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation. , 2006, Bioconjugate chemistry.

[35]  R. J. Solá,et al.  Modulation of protein biophysical properties by chemical glycosylation: biochemical insights and biomedical implications , 2007, Cellular and Molecular Life Sciences.

[36]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[37]  D. A. Baker,et al.  Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic. , 2008, Biophysical journal.

[38]  R. J. Solá,et al.  Effect of PEG modification on subtilisin Carlsberg activity, enantioselectivity, and structural dynamics in 1,4‐dioxane , 2008, Biotechnology and bioengineering.